Efficient amplification of melanoma-specific CD8+ T cells usingartificial antigen presenting complex

다국어 초록 (Multilingual Abstract)

In vitro large amplification of tumor-specific cyto-toxic T lymphocytes (CTLs) and adoptive transfer of these cells is one of the most promising approaches to treat malignant diseases in which an effective immune response is not achieved by active immuni-zation. However, generating sufficient numbers of tumor-specific CTLs stimulated with autologous antigen presenting cells (APCs) in vitro is one of the most problematic steps in the adoptive cell transfer (ACT) therapy. To circumvent this problem, we have developed an artificial antigen presenting complex (aAPCs) using MHC class I molecules loaded with a sults show that TRP-2-specific CD8+ T cells elicited by immunization with recombinant adenovirus expressing the mini-gene epitope are efficiently stimulated and amplified in vitro to a greater extent by aAPCs than by natural splenic APCs. These aAPC-induced CTLs recognized endogenously pro-cessed antigens present on B16F10 melanoma cells. Efficient stimulation and proliferation of antigen- specific T cells was also confirmed using ovalbumin peptide-loaded aAPCs and OT-I TCR transgenic cells. These results demonstrate that prior in vivo immunization, which increases the precursor fre-quency, simplifies posterior expansion of tumor- specific CD8+ T cells, and aAPCs is superior to autologous APC for in vitro amplification. This prime and expand regimen can be an alternative method for large amplification of rare tumor-specific CTLs and aAPCs should be a useful tool for ACT immunotherapy.

참고문헌 (Reference)

1 "transporter associated with antigen processing -indepen-dent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences lo-cated at the amino- but not carboxyl-terminus of the peptide. J Immunol 1994" 381-7, 1994

2 "immune recognition of self and altered self. J Exp Med 1994" 1-4, 1994

3 "Tumor-infiltrating lymphocytes ex-hibiting high ex vivo cytolytic activity fail to prevent murine mel-anoma tumor growth in vivo" 161 : 2187-2194, 1998

4 "Romagnani S. Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immuno-deficiency virus type 1 infection. J Exp Med 1994" 489-95, 1994

5 "Roles of tumour localization, second signals and cross priming in cy-totoxic T-cell induction" 411 : 1058-1064, 2001

6 "Infusion of cytotoxic T cells for the prevention and treat-ment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients" 92 : 1549-1555, 1998

7 "In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen com-plexes on microspheres (large multivalent immunogen)" 170 : 228-235, 2003

8 "Immunologic and ther-apeutic evaluation of a synthetic peptide vaccine for the treat-ment of patients with metastatic melanoma" 4 : 321-327, 1998

9 "Identification of a shared HLA-A*0201- restricted T-cell epitope from the melanoma antigen ty-rosinase-related protein 2 (TRP2)" 58 : 4895-4901, 1998

10 "High frequencies of naive Melan-A/MART-1-speciflc CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals" 190 : 705-715, 1999

11 "Ex vivo induction and expansion of anti-gen-specific cytotoxic T cells by HLA-Ig-coated artificial anti-gen-presenting cells" 9 : 619-624, 2003

12 "Ex vivo expansion of poly-clonal and antigen-specific cytotoxic T lymphocytes by artifi-cial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB" 20 : 143-148, 2002

13 "Direct visualization of antigen-specific T cels: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cer-ebrospinal fluid from HAM/TSP patients" 95 : 7568-7573, 1998

14 "Cancer regression and autoimmunity in pa-tients after clonal repopulation with antitumor lymphocytes" 298 : 850-854, 2002

15 "Artificial cell surface constructs for studying receptor-ligand contributions to lymphocyte activation" 209 : 47-57, 1997

16 "Adoptive-cell-transfer therapy for the treatment of patients with cancer" 3 : 666-675, 2003

17 "A simplified system for generating recombinant adenoviruses" 95 : 2509-2514, 1998